Search alternatives:
significant interest » significant increase (Expand Search), significant interaction (Expand Search), significant increases (Expand Search)
significant promise » significant rise (Expand Search), significant progress (Expand Search), significant problem (Expand Search)
promise decrease » point decrease (Expand Search)
Showing 61 - 80 results of 14,523 for search '(( significant promise decrease ) OR ( significant interest (decrease OR increase) ))', query time: 0.58s Refine Results
  1. 61
    Assessing the Potential of <i>N</i>‑Butyl‑l‑deoxynojirimycin (l‑NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent

    Assessing the Potential of <i>N</i>‑Butyl‑l‑deoxynojirimycin (l‑NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent by Anna Esposito (2400814)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 62
    Correlation plot across various traits of interest.

    Correlation plot across various traits of interest. by Umesh Kumar Garg (17605149)

    Published 2023
    Save to List
    Saved in:
  3. 63
    This plot illustrates the phenome-wide association study (PheWAS) results for the genetic variant of interest.

    This plot illustrates the phenome-wide association study (PheWAS) results for the genetic variant of interest. by Sudipta Chakraborty (87084)

    Published 2024
    Save to List
    Saved in:
  4. 64
    Participant flow (CONSORT diagram).

    Participant flow (CONSORT diagram). by David J. Diemert (8135568)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 65
    Geometric mean anti-<i>Na</i>-GST-1 IgG levels over time by vaccine group, as measured by ELISA (Arbitrary Units).

    Geometric mean anti-<i>Na</i>-GST-1 IgG levels over time by vaccine group, as measured by ELISA (Arbitrary Units). by David J. Diemert (8135568)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 66
    Demographic and baseline characteristics of study participants by vaccine group.

    Demographic and baseline characteristics of study participants by vaccine group. by David J. Diemert (8135568)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 67
    Geometric mean anti-<i>Na</i>-GST-1 IgG subclass levels over time.

    Geometric mean anti-<i>Na</i>-GST-1 IgG subclass levels over time. by David J. Diemert (8135568)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 68
    Anti-<i>Na</i>-GST-1 IgG antibody levels and seroresponse rates by vaccine group and study day.

    Anti-<i>Na</i>-GST-1 IgG antibody levels and seroresponse rates by vaccine group and study day. by David J. Diemert (8135568)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 69
    Number and percentage of participants experiencing solicited injection site and systemic reactions by maximum severity and vaccine group.

    Number and percentage of participants experiencing solicited injection site and systemic reactions by maximum severity and vaccine group. by David J. Diemert (8135568)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 70
    Description and type of the variables of interest, regarding the match and tournament.

    Description and type of the variables of interest, regarding the match and tournament. by Maria Palau (18720842)

    Published 2024
    Save to List
    Saved in:
  11. 71
    Designated region of interests (ROI) indicated on the panoramic radiograph.

    Designated region of interests (ROI) indicated on the panoramic radiograph. by Nilüfer Ersan (16475129)

    Published 2023
    Save to List
    Saved in:
  12. 72
    Data from: Colony losses of stingless bees increase in agricultural areas, but decrease in forested areas

    Data from: Colony losses of stingless bees increase in agricultural areas, but decrease in forested areas by Malena Sibaja Leyton (18400983)

    Published 2025
    “…We found that colony losses during the rainy season decreased with higher abundance of forested areas and increased with higher abundance of agricultural area around meliponaries. …”
    Save to List
    Saved in:
  13. 73
    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for Parkinson’s Disease

    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for... by Javier García-Cárceles (2073898)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 74
    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for Parkinson’s Disease

    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for... by Javier García-Cárceles (2073898)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 75
    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for Parkinson’s Disease

    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for... by Javier García-Cárceles (2073898)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 76
    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for Parkinson’s Disease

    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for... by Javier García-Cárceles (2073898)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 77
    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for Parkinson’s Disease

    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for... by Javier García-Cárceles (2073898)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 78
    The “women and gender” topic broadened significantly after 1990.

    The “women and gender” topic broadened significantly after 1990. by Stephan Risi (11973193)

    Published 2022
    Save to List
    Saved in:
  19. 79
    Imputed HLA alleles and its correlation with variant of interest—rs9274619:A.

    Imputed HLA alleles and its correlation with variant of interest—rs9274619:A. by Margaret Sunitha Selvaraj (13994016)

    Published 2022
    Save to List
    Saved in:
  20. 80
    Sensitivity analysis for optimal case, (A) Change in interest rate; (B) Change in lifetime.

    Sensitivity analysis for optimal case, (A) Change in interest rate; (B) Change in lifetime. by Muhammad Alam Zaib Khan (16877184)

    Published 2023
    Save to List
    Saved in:

Search Tools: